Previous Article | Next Article 
J Virol, April 1998, p. 3412-3417, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mutations of the Human Immunodeficiency Virus Type
1 p6Gag Domain Result in Reduced Retention of Pol
Proteins during Virus Assembly
Xiao-Fang
Yu,1,*
Liza
Dawson,1
Chun-Juan
Tian,1
Charles
Flexner,2 and
Markus
Dettenhofer1
Department of Molecular Microbiology and
Immunology, Johns Hopkins University School of Hygiene and Public
Health,1 and
Department of Medicine and
Pharmacology and Molecular Sciences,2 Johns
Hopkins University School of Medicine, Baltimore, Maryland 21205
Received 29 October 1997/Accepted 12 January 1998
One of the crucial steps in the assembly of the human
immunodeficiency virus type 1 (HIV-1) and other retroviruses is
the incorporation and retention of all the key viral enzymes in
released virions. The viral enzymes protease, reverse transcriptase,
and integrase of HIV-1 are initially synthesized as Gag-Pol fusion polyproteins. It has been shown that the incorporation of Gag-Pol polyproteins during virus assembly requires the Gag domains that are
shared by the Gag and Gag-Pol precursors. We now report that truncation
of the C-terminal p6 domain of HIV-1 Gag, which is present in the Gag
precursor but not in the Gag-Pol precursor, drastically reduced the
amount of Pol proteins in the mutant virions. Mutations in the
lentivirus conserved motif P(T/S)APP in p6 also drastically reduced the
amount of Pol proteins in mutant virions. The steady-state levels of
Gag-Pol precursors and cleaved Pol proteins in the transfected cells
were not affected by mutations in p6. The incorporation of unprocessed
Gag-Pol precursors into p6 mutant virions was detected when the viral
protease was mutated, suggesting that the interactions among mutant Gag
molecules and Gag-Pol precursors were not significantly affected. These
results suggest that the p6 domain of HIV-1 Gag may play an important role in recruiting or retaining cleaved Pol proteins during virus assembly.
*
Corresponding author. Mailing address: Department of
Molecular Microbiology and Immunology, The Johns Hopkins University
School of Hygiene and Public Health, Baltimore, MD 21205. Phone: (410) 955-3768. Fax: (410) 614-8263. E-mail: xfyu{at}jhsph.edu.
This article has been cited by other articles:
-
Fossen, T., Wray, V., Bruns, K., Rachmat, J., Henklein, P., Tessmer, U., Maczurek, A., Klinger, P., Schubert, U.
(2005). Solution Structure of the Human Immunodeficiency Virus Type 1 p6 Protein. J. Biol. Chem.
280: 42515-42527
[Abstract]
[Full Text]
-
Hemonnot, B., Cartier, C., Gay, B., Rebuffat, S., Bardy, M., Devaux, C., Boyer, V., Briant, L.
(2004). The Host Cell MAP Kinase ERK-2 Regulates Viral Assembly and Release by Phosphorylating the p6gag Protein of HIV-1. J. Biol. Chem.
279: 32426-32434
[Abstract]
[Full Text]
-
Bleiber, G., Peters, S., Martinez, R., Cmarko, D., Meylan, P., Telenti, A.
(2004). The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro. J. Gen. Virol.
85: 921-927
[Abstract]
[Full Text]
-
Cen, S., Niu, M., Saadatmand, J., Guo, F., Huang, Y., Nabel, G. J., Kleiman, L.
(2004). Incorporation of Pol into Human Immunodeficiency Virus Type 1 Gag Virus-Like Particles Occurs Independently of the Upstream Gag Domain in Gag-Pol. J. Virol.
78: 1042-1049
[Abstract]
[Full Text]
-
Freed, E. O.
(2002). Viral Late Domains. J. Virol.
76: 4679-4687
[Full Text]
-
Muller, B., Patschinsky, T., Krausslich, H.-G.
(2002). The Late-Domain-Containing Protein p6 Is the Predominant Phosphoprotein of Human Immunodeficiency Virus Type 1 Particles. J. Virol.
76: 1015-1024
[Abstract]
[Full Text]
-
Demirov, D. G., Orenstein, J. M., Freed, E. O.
(2002). The Late Domain of Human Immunodeficiency Virus Type 1 p6 Promotes Virus Release in a Cell Type-Dependent Manner. J. Virol.
76: 105-117
[Abstract]
[Full Text]
-
Peters, S., Munoz, M., Yerly, S., Sanchez-Merino, V., Lopez-Galindez, C., Perrin, L., Larder, B., Cmarko, D., Fakan, S., Meylan, P., Telenti, A.
(2001). Resistance to Nucleoside Analog Reverse Transcriptase Inhibitors Mediated by Human Immunodeficiency Virus Type 1 p6 Protein. J. Virol.
75: 9644-9653
[Abstract]
[Full Text]
-
Chen, C., Li, F., Montelaro, R. C.
(2001). Functional Roles of Equine Infectious Anemia Virus Gag p9 in Viral Budding and Infection. J. Virol.
75: 9762-9770
[Abstract]
[Full Text]
-
Khan, M. A., Aberham, C., Kao, S., Akari, H., Gorelick, R., Bour, S., Strebel, K.
(2001). Human Immunodeficiency Virus Type 1 Vif Protein Is Packaged into the Nucleoprotein Complex through an Interaction with Viral Genomic RNA. J. Virol.
75: 7252-7265
[Abstract]
[Full Text]
-
Accola, M. A., Strack, B., Göttlinger, H. G.
(2000). Efficient Particle Production by Minimal Gag Constructs Which Retain the Carboxy-Terminal Domain of Human Immunodeficiency Virus Type 1 Capsid-p2 and a Late Assembly Domain. J. Virol.
74: 5395-5402
[Abstract]
[Full Text]
-
Sei, S., Yang, Q.-e., O'Neill, D., Yoshimura, K., Nagashima, K., Mitsuya, H.
(2000). Identification of a Key Target Sequence To Block Human Immunodeficiency Virus Type 1 Replication within the gag-pol Transframe Domain. J. Virol.
74: 4621-4633
[Abstract]
[Full Text]
-
Dettenhofer, M., Yu, X.-F.
(1999). Proline Residues in Human Immunodeficiency Virus Type 1 p6Gag Exert a Cell Type-Dependent Effect on Viral Replication and Virion Incorporation of Pol Proteins. J. Virol.
73: 4696-4704
[Abstract]
[Full Text]
-
Liu, B., Dai, R., Tian, C.-J., Dawson, L., Gorelick, R., Yu, X.-F.
(1999). Interaction of the Human Immunodeficiency Virus Type 1 Nucleocapsid with Actin. J. Virol.
73: 2901-2908
[Abstract]
[Full Text]